Gene · 3205
Papers4,255
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 4,255
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epimutations and Their Effect on Chromatin Organization: Exciting Avenues for Cancer Treatment. | Cancers (Basel) | 2022 | 36612210 | PubTator, text mining | PubMed |
| The SMARCD Family of SWI/SNF Accessory Proteins Is Involved in the Transcriptional Regulation of Androgen Receptor-Driven Genes and Plays a Role in Various Essential Processes of Prostate Cancer. | Cells | 2022 | 36611918 | PubTator, text mining | PubMed |
| An Overview of 10th Anniversary of Cells-Advances in Cell Nuclei: Function, Transport and Receptors. | Cells | 2022 | 36611849 | PubTator, text mining | PubMed |
| Nuclear envelope, chromatin organizers, histones, and DNA: The many achilles heels exploited across cancers. | Front Cell Dev Biol | 2022 | 36589746 | PubTator, text mining | PubMed |
| Role of Nidogen-2 in diagnosis and prognosis of head and neck squamous cell carcinoma: A systematic review. | J Oral Maxillofac Pathol | 2022 | 36588846 | PubTator, text mining | PubMed |
| Hematologic dysfunction in cancer: Mechanisms, effects on antitumor immunity, and roles in disease progression. | Front Immunol | 2022 | 36561751 | PubTator, text mining | PubMed |
| Primary Breast Angiosarcoma: Comparative Transcriptome Analysis. | Int J Mol Sci | 2022 | 36555675 | PubTator, text mining | PubMed |
| The Mutual Relationship between Glycosylation and Non-Coding RNAs in Cancer and Other Physio-Pathological Conditions. | Int J Mol Sci | 2022 | 36555445 | PubTator, text mining | PubMed |
| Upfront Screening by Quantitative Real-Time PCR Assay Identifies NUP98::NSD1 Fusion Transcript in Indian AML Patients. | Diagnostics (Basel) | 2022 | 36553008 | PubTator, text mining | PubMed |
| Real-Time Characterization of Clonal Fate Decisions in Complex Leukemia Samples by Fluorescent Genetic Barcoding. | Cells | 2022 | 36552809 | PubTator, text mining | PubMed |
| Identification of prognostic values of the transcription factor-CpG-gene triplets in lung adenocarcinoma: A narrative review. | Medicine (Baltimore) | 2022 | 36550923 | PubTator, text mining | PubMed |
| Leukemic stem cells and advances in hematopoietic stem cell transplantation for acute myeloid leukemia: a narrative review of clinical trials. | Stem Cell Investig | 2022 | 36540355 | PubTator, text mining | PubMed |
| The dynamics of three-dimensional chromatin organization and phase separation in cell fate transitions and diseases. | Cell Regen | 2022 | 36539553 | PubTator, text mining | PubMed |
| The potential of PARP inhibitors in targeted cancer therapy and immunotherapy. | Front Mol Biosci | 2022 | 36533080 | PubTator, text mining | PubMed |
| Identification of molecular subtypes based on liquid-liquid phase separation and cross-talk with immunological phenotype in bladder cancer. | Front Immunol | 2022 | 36518754 | PubTator, text mining | PubMed |
| Novel Molecular Insights into Leukemic Evolution of Myeloproliferative Neoplasms: A Single Cell Perspective. | Int J Mol Sci | 2022 | 36499582 | PubTator, text mining | PubMed |
| Viewing AML through a New Lens: Technological Advances in the Study of Epigenetic Regulation. | Cancers (Basel) | 2022 | 36497471 | PubTator, text mining | PubMed |
| Targeting Menin and CD47 to Address Unmet Needs in Acute Myeloid Leukemia. | Cancers (Basel) | 2022 | 36497385 | PubTator, text mining | PubMed |
| Multilevel view on chromatin architecture alterations in cancer. | Front Genet | 2022 | 36468037 | PubTator, text mining | PubMed |
| Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients. | Clin Epigenetics | 2022 | 36461127 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3205/papers?page=31